Course Description
A discussion of the real-world implications of the novel coronavirus on patient resuscitation, new resuscitation guidelines and long-term patient outlook.
Course Learning Objective
Participants will gain understanding of:
· Provider safety guidance for resuscitation of patients with suspected or confirmed COVID-19
· educating communities on the importance of CPR
· the 2020 AHA Resuscitation Guidelines
· managing long-term neurological outcomes
Intended Audience
All healthcare professionals
American Heart Association (AHA)-ATVB
Session：Mechanism of Vascular Disease, Immunity and Metabolic Disorders
Course Description
ATVB is the Council on Arteriosclerosis, Thrombosis and Vascular Biology of American Heart Association (AHA). ATVB engages scientists and clinicians working to improve the prevention, diagnosis and treatment of atherosclerotic, vascular, and thrombotic diseases in the US and worldwide. Council membership includes investigators with interests that range from discovery science to clinical research. We promote international collaboration and network in cardiovascular Research.
In cooperation with Chinese American Academy of Cardiology (CAAC), we started the collaboration with GW-ICC since 2015 and jointly hosted the ATVB@GW-ICC论坛 for the past 5 years. The scientific theme of this session is “Mechanism of Vascular Disease, Immunity and Metabolic Disorders”.
Course Learning Objective
Exchange scientific discovery and opinions
Intended Audience
Basic Science researchers and clinical researchers/doctors
American Heart Association (AHA)-BCVS
Course Description
Cardiovascular disease (CVD) is the leading cause of death in the developed countries and China. The Council on Basic Cardiovascular Science (BCVS, the second largest council of AHA) was created in 1999 which contributes to the mission and objectives of the AHA through efforts in the fields of basic science as to cardiovascular disease related research and education. BCVS’ goal is to improve understanding of mechanisms of basic cardiovascular regulation to support the development of new therapies and insights into clinical CVD. To advance cardiovascular research and practice in China, the Great Wall International Congress of Cardiology (GWICC) and BCVS jointly established the AHA-BCVS@GWICC since 2011. We have witnessed a great success in the past nine years.
The central theme of AHA-BCVS@GWICC this year will be “New Frontiers in Cardiovascular Research”. Five sessions will be designated as BCVS@GWICC. 1) Kinase Signaling and Cardiac injury. Critical roles of kinases-mediated signaling in cardiovascular injury will be presented by leading experts in this filed, including Professor Walter Koch of Temple University; Professor Maria Kontaridis of Harvard University, Professor Hind Lal of University of Alabama at Birmingham, and Professor Xuejun Wang of University of South Dakota. 2) Molecular Mechanisms and Intervention of Cardiac Repair. Current advance in the mechanisms of cardiovascular disease will be reviewed by the world leaders in this field, including Professor Rong Tian at University of Washington, Professor Elizabeth McNally of Northwestern University (Chair of BCVS), Professor Sakthivel Sadayappan of University of Cincinnati, and Professor Ying Ge of University of Wisconsin-Madison. 3) Metabolic Disorders and Cardiovascular Injury. Cutting-edge research progress will be summarized by leaders in this filed, including Professor Yajing Wang of Thomas Jefferson University, Professor Lu Cai of University of Louisville, Professor Vahagn Ohanyan of North East Ohio Medical University, Professor Chen Yan of University of Rochester, and Professor of Changcheng Zhou of University of California, Riverside. 4) Cell-Cell Communication and Cardiac Injury. Most recent development in this filed will be presented by leading experts including Professor Gangjian Qin of University of Alabama at Birmingham, Professor Asa Gustafsson of University of California San Diego, Professor Jiang Chang of Texas A&M University, and Professor Jay Zhang of University of Alabama at Birmingham (vice Chair of BCVS). 5) Novel Mechanisms and Protective Strategies against Heart Failure. Most recent development in this field will be presented by leading experts including Professor Yibin Wang of University of California at Los Angeles, Professor Joseph Hill of UT Southwestern Medical Center (Chief Editor, Circulation), Professor Jeffery Molkentin of Cincinnati Children's Hospital Medical Center (HHMI Professor), and Professor Steven Houser of Temple University (past president of AHA).
Course Learning Objective
Upon conclusion of this BCVS Expert Forum, participants should be able to:
Discuss the novel mechanisms and pluripotent stem cell treatment in Heart failure and Cardiomyopathy.
Learn of the novel signaling mechanisms of Cardiac Injury
Focus on the importance of mitochondrial dysfunction in Cardiac Injury
Recognize the role of macrophage and stem cell in the metabolic syndrome associated CVD
Intended Audience
Basic and translational cardiologists.
American Heart Association (AHA)-CVDY
Course Description
The presenters will provide a state of the art update on the management of heart failure in children.
Course Learning Objective
The speakers will provide the latest knowledge, clinical practice, and innovations that can shape the future of heart failure management in children including special topics on myocarditis and mechanical circulatory support.
Intended Audience
Practitioners who care for children and young adults with heart failure.
American Heart Association (AHA)/CPR
Session: From Guideline to Practice: Evidence-review Process, High-tech Application in Medical Training Solution, and Update of Emergency Cardiovascular Guideline
Course Description
This course will help the audience to understand the full process of guideline development, the solution of the translation to the clinical practice and the new updates of emergency cardiovascular guideline.
Course Learning Objective
To understand the evidence-review process of the Emergency Cardiovascular Guideline development.
To promote the translation from the ECC guideline to the practice in clinical setting.
To learn the new concept and high-tech in the ECC training solution.
To discuss the updates of the new ECC guideline of 2020.
Intended Audience
Medical Personnel of Pre/In-hospital Emergency Department, Cardiologist, ICU/CCU and those responsible for emergency response.
American Stroke Association (ASA)
Session: Explaining Unexplained Stroke: Atrial Fibrillation and Beyond.
Course Description
Atrial fibrillation (AF) is associated with stroke risk, but several lines of evidence call into question the prevailing concept that the fibrillation itself is the direct cause of stroke in patients with atrial dysfunction. Strokes in patients with AF may occur long before or after the detection of AF; the atrium may be functionally fibrillating even when the electrocardiogram is in normal sinus rhythm; the vast majority of thrombi are found not in the left atrium itself but in the appendage, which may have various morphologies associated with differential risks; and patients with genetic causes of AF may develop stroke even before the onset of AF. Furthermore, while recent studies provide evidence that long-term cardiac monitoring detects AF in many patients with unexplained stroke, the cause of presumed embolic stroke remains uncertain in 70% of patients who undergo monitoring for as long as 3 years, suggesting that better ways of detecting sources of emboli are needed. Additional evidence suggests that markers of atrial dysfunction are also associated with risk of stroke, even in patients without AF. These other markers include other supraventricular arrhythmias, elevated levels of N terminal pro-BNP and troponin, genetic markers, subtle P-wave abnormalities, echocardiographic measures, and left atrial appendage variants. Detection of these biomarkers, as alternative risk markers to the diagnosis of AF in stroke patients, has the advantage of precluding the need for long-term monitoring. Post-hoc analyses of randomized trials also provide data to support the notion that anticoagulation may be an effective preventive strategy among patients with atrial abnormalities or extreme levels of physiological markers of atrial function, independent of finding AF. Taken together these data suggest an emerging new conceptualization of the role of the cardiac left atrium in stroke risk and prevention, one that moves beyond atrial fibrillation alone to a more nuanced appreciation of the relevance of atrial dysfunction to stroke risk. This session will review the data on subclinical AF and atrial cardiopathy and stroke risk, cardiac monitoring for the detection of AF, and emerging data on therapeutic implications of these findings.
Course Learning Objective
Participants will gain the understanding of:
The epidemiology of subclinical AF and its associated stroke risk
The relationship of biomarkers of atrial dysfunction to stroke risk
Therapeutic implications of the concept of atrial cardiopathy for stroke prevention
Intended Audience
All healthcare providers
Argentine Society of Cardiology
Course Description
Focus on changing aspects of aortic stenosis
Course Learning Objective
Make available to the participants an updated vision of the frequent problems in aortic stenosis in clinical practice
Intended Audience
Clinical cardiologist
Brazilian Society of Cardiology (SBC)
Course Description
A didactic activity that will review the major topics related to the diagnostic assessment and the interventional treatment of aortic valve stenosis
Course Learning Objective
To provide an updated overview of the current management of aortic valve stenosis and transcatheter aortic valve replacement
Intended Audience
General cardiologists, interventional cardiologists, cardiovascular surgeons
Cardiological Society of India (CSI)
Course Description I
Session on Heart Failure and Cardiomyopathy
Topics: 1.Overview of the Burden of Heart Failure
2. Management of Heart Failure: Practical Issues
Course Learning Objective
1.To know the global burden of the Heart Failure along with special emphasis on Asian Scenario
2.To have comprehensive idea about the modalities of modern treatment as well as standard care of Heart Failure
Intended Audience
1.Physicians practicing Cardiology
2. Cardiologists
3. Heart Failure Specialists
Course Description II
Course Learning Objective
To know about the NOACS very commonly used now-a-days with special situations like CAD with PCI with A. fibrillation which may need special care.
Similarly there are uses of NOACs beyond A. Fib like in CVA or HF or LV thrombus, PTE or even in special IHD set up.
Intended Audience
1.Physicians practicing Cardiology
2.Interventional Cardiologists
3.Cardiologists
Chinese American Academy of Cardiology (CAAC)
Session 1: New challenges and opportunities in pediatric cardiology
Course Description
-CAAC/GWICC joint pediatric cardiology session
Course Learning Objective
-Discuss the new updates on the pediatric cardiology research and clinical best practice topics for congenital and acquired heart diseases
Intended Audience
-Pediatric, and adult cardiologists;
-Other general and specialty physicians and other professionals who care for children with congenital and acquired heart diseases, e.g. pediatricians, family physicians, nurses, etc.
Session 2: New challenges and opportunities in fetal cardiology
Course Description
-CAAC/GWICC Joint Fetal Cardiology Session
Course Learning Objective
-Discuss the new updates on the fetal cardiology research and clinical best practice topics for congenital and acquired heart diseases
Intended Audience
-Pediatric, and adult cardiologists;
-Other general and specialty physicians and other professionals who care for children with congenital and acquired heart diseases, e.g. OB, ultrasound/echocardiology physicians, etc.
Session 3: Update in Cardiovascular Advancements
Course Description
-Our sessions will feature lectures and discussions by distinguished Cardiologists who will provide current information on the status and future directions of cardiovascular medicine. The experts will highlight recent progress in the diagnosis and treatment of cardiovascular disease, as well as new therapeutic modalities.
Course Learning Objective
-Discuss the latest advances in cardiovascular disease
-Highlight advanced Echo imaging in structural heart diseases, acute pulmonary embolism and right heart failure
-Update of new approaches to clinical therapy of peripheral vascular disease and hypertrophic cardiomyopathy
Intended Audience
-cardiologists, cardiovascular surgeons, internists, clinical researchers, nurses, technicians, and all interested in cardiovascular disease
Session：Metabolic Disease, Thrombogenesis and Cardiac Repairing
Course Description
CAAC, the Chinese American Academy of Cardiology is an international professional organization in Cardiovascular Medicine and research based on United States. Under the roof of CAAC, academic clinical and research cardiovascular professionals harmonically work together. Our mission is to establish a platform to facilitate communication, to promote collaboration, and to support career development for cardiovascular professional in the world. We encourage and advocate outstanding science from our members. We support career development of younger generation of cardiovascular scientists and physicians. We collaborate with colleagues in other organizations in the world to advance high standard cardiovascular research and medicine. We started collaboration with GW-ICC since 2014 and jointly hosted the CAAC@GW-ICC论坛 for the past 6 years. The scientific theme of this session is “Metabolic Disease, Thrombogenesis and Cardiac Repairing”.
Chinese American Heart Association (CNAHA)
Session 1: Therapies for Advanced Heart Failure
Course Description
Emerging therapies for advanced heart failure, what can we offer when conventional drug treatment has failed.
Course Learning Objective
1. To learn emerging therapeutic options for advanced heart failure
2. To learn benefits and patient selection for percutaneous heart valve intervention in heart failure patients
3. To learn indication and patient selection for mechanical circulatory support (MCS) in advanced heart failure.
4. To learn the role of MCS in critical COVID19 patients.
Intended Audience
General cardiologists, interventional cardiologists, heart failure specialists, heart failure team members.
Session 2: Standardized Cardiology Training
Course Description: Standardized Cardiology Training
We will compare the similarities and differences between the Chinese and American cardiology training programs using recent graduates as examples. The history, standards, guidelines, successes and challenges of cardiology training pathways in China and United States will be discussed.
Course Learning Objective
To understand the current state of standardized cardiology training programs in China.
To understand the guideline and structure of cardiology training program in the U.S.
To address challenges and share best practices in cardiology training in China and the U.S.
Intended Audience
Medical students, medical residents, practicing cardiologists, faculty and administrators in cardiology training programs in academic centers and clinical programs.
Session 3: Current Issues in AF Management
Course Description
Discuss new advancement in atrial fibrillation ablation and management
Course Learning Objective
Ablation strategy beyond pulmonary vein isolation
Anticoagulation strategy after successful ablation
Intended Audience
Cardiologist and Cardiac electrophysiologist
Session 4: Update on Percutaneous Valve Innervation
Course Description
Update of percutaneous heart valve intervention, both internationally and within China.
Course Learning Objective
To learn the current technology and clinical applications of percutaneous aortic and mitral valve interventions.
To understand future utility and challenges of percutaneous aortic and mitral valve interventions in China.
Intended Audience
Interventional and general cardiologists involved in managing valvular heart disease.
Session 5: Basic/Translational Cardiovascular Research and Novel Technologies.
Course Description:
Basic/Translational Cardiovascular Research and Novel Technologies.
Course Learning Objective:
International prestigious physicians and scientists will present their novel scientific discoveries and inspire insightful idea exchanges and discussions.
Intended Audience:
All GW-ICC attendees.
Session 6: Multi-modality Cardiac Imaging
Course Description: Standardized Cardiology Training
We will discuss several fast progressing cardiac imaging issues, such as myocarditis, mitral valve disease and thromboembolic disease. Various imaging modalities, such as cardiac MRI and echocardiography will be emphasized.
Course Learning Objective
To understand the role of cardiac imaging in myocarditis
To understand the history and perspective of mitral disease
To address the use of echocardiography in thromboembolic diseases
Intended Audience
Medical students, medical residents, practicing cardiologists
European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Session 1: PFO-associated stroke
Course Description
PFO-associated stroke
Course Learning Objective
To learn PFO anatomy, stroke mechanisms, new nomenclature, diagnosis of PFO, evidence and how to close a PFO, who to offer PFO closure
Intended Audience
General cardiologists, interventional cardiologists, stroke teams
Session 2: LAAO: state of the art
Course Description
LAAO state of the art
Course Learning Objective
To learn LAAO step by step procedure, complications prevention, available devices, post-procedural management and current LAAO indications.
Intended Audience
Interventional cardiologists
General cardiologists
Stroke teams
Session 3: Trans-Catheter Aortic Valve Replacement in Special Patients Subsets – What are the Remaining Challenges?
Course Description
TAVR in special non-classical AS population
Course Learning Objective
To learn if indications for TAVR may be expanded to non-classical AS patients such as bicuspid AV, pure aortic regurgitation, failed bioprostheses with PPM, patients with PVD with no trans-femoral access
Intended Audience
Interventional cardiologists
General cardiologists
Valve disease experts
European Atherosclerosis Society （EAS）
Course Description
The new era in dyslipidemia management
• Atherosclerotic vascular disease and dyslipidemia in China: Scope of the problem: Colleague from China
• How did the new guidelines change the landscape in lipid lowering: Lale Tokgozoglu
• Is there room for triglyceride lowering? Colleague from China
• New therapeutic agents: Kosh Ray
Course Learning Objective
Participants in the session will learn the key aspects of the European guidelines on the management of dyslipidaemia developed by European Society of Cardiology & European Atherosclerosis Society in 2019 – including evaluation of cardiovascular risk, the targets and goals specified, the strategies recommended to reach them, and recent developments in therapeutic approaches. Further, the different experiences and challenges found between Europe and China related to atherosclerotic vascular disease and management of dyslipidaemias will be discussed.
Intended Audience
Understanding the role of lipids in health and disease is important for a broad spectrum of different professionals working in health care and in society at large. This programme is primarily suited to physicians in internal medicine, cardiology, diabetology, endocrinology and in general practice. Outside this group, this educational programme is highly relevant to nurses working in lipid clinics, in cardiovascular prevention, in diabetes and in many other clinics training care of patients with cardiovascular or metabolic diseases. Others who will find the educational content of this programme highly relevant include scientists working in cardiovascular epidemiology and in basic cardiovascular research, and persons employed in the pharma industry.
European Heart Journal (EHJ)
Session I: Highlights in clinical and translational cardiology: the year in EHJ and CVR
Course Description
A session dedicated to a wrap up of the most important studies published in 2020 in ischemic heart disease and in imaging in the European Heart Journal and in translational research in Cardiovascular Research
Course Learning Objective
Learning about the most important and impactful papers of the year in mechanisms, prevention and treatment of ischemic heart disease, in imaging (echocardiography and cardiac magnetic resonance) and in translational cardiology from an European and Chinese perspective.
Intended Audience
Clinical cardiologists and translational scientists
Session II: ESC Journal Family: the year in Interventional Cardiology
Course Description
A session dedicated to a wrap up of the most important papers of 2020 in interventional cardiology, built in collaboration with EuroIntervention.
Course Learning Objective
Learning about the most important and impactful papers of the year in interventional cardiology from an European and Chinese perspective.
Intended Audience
Interventional cardiologist and general cardiologists
Session III: ESC Journal Family: the year in Arrhythmias
Course Description
This course will give an update on the most relevant topics around arrhythmias and electrophysiology with a focus on the most important scientific findings from technical innovations and clinical trials. It will cover the 4 focus topics: Atrial Fibrillation, Ventricular Tachycardia, Sudden Cardiac Death, and Arrhythmias & Data Science
Course Learning Objective
Understand the key messages from the new 2020 ESC AF Guidelines and the EAST Trial; recognize the potential of catheter ablation of ventricular tachycardia but also risks and complications; learn about the challenges in understanding and effectively preventing SCD, get insights into the latest clinical trials on SCD prevention. Review the progress in cardiac pacing generated by new modes of pacing of the specific conduction system. Explore the opportunities of big data analysis to generate real world evidences and the opportunities and limitations of machine learning and artificial intelligence in the field of arrhythmias.
Intended Audience
Cardiologists, electrophysiologists, general practitioners, medical students, academic nurses
Session IV: ESC Journal Family: the year in Heart Failure, Cardiomyopathies, Congenital Heart Disease and Valvular Heart Disease
Course Description
- Papers published in the European Heart Journal and the European Journal of Heart Failure, with highest recognition and impact and citations.
Course Learning Objective
- Emerging issues in the fields of Heart Failure
Intended Audience
Researchers and clinicians, aiming to be updated in the fields of Heart Failure and co-morbidities
Session V: ESC Journal Family: the year in Prevention
Course Description
- Papers published in the European Journal of Preventive Cardiology, with highest recognition and impact and citations.
Course Learning Objective
- Emerging issues in the fields of Cardiovascular Prevention
Intended Audience
Researchers and clinicians, aiming to be updated in the fields of CV prevention, rehabilitation and sport cardiology
European Heart Rhythm Association (EHRA)
Course Description I: AF
The course will be an update on late developments in atrial fibrillation. How to manage patients, what are the most promising ablation techniques.
Course Learning Objective
The objective is to provide the attendees with an updated view on how to manage AF patients, with special emphasis in AF therapy and AF patient management.
Intended Audience
The intended audience will be cardiologists seeing patients with AF and arrhythmia specialists
Course Description II: VT Course:
Novelties, tips, and tricks to improve results of VT ablation
Course Learning Objective:
To familiarize attendees with the Results prognostic, and technical novelties in the field of VT ablation.
Intended Audience
Cardiologist treating ventricular arrihythmias.
European Society of Cardiology (ESC)
Session 5: ESC/GW-ICC Joint Session for the Young
Course Description:
-Precision medicine aims for the highest level of personalization in diagnostics and therapy that is achieved via genomics and digital health. This session will provide newest information from this dynamic fields.
Course Learning Objective:
-How to implement precision medicine in cardiology.
Intended Audience:
-Mainly clinicians
Heart and Health Foundation of Turkey（HHFT）
Session I： Challenges in the treatment of ventricular arrhythmias
Course Description I
An advanced case based discussion of management of ventricular tachyarrhythmias
Course Learning Objective
Having attended the session the audience will be informed about the challenging aspects of ventricular arrhythmias. The role of ECG in the assumpon of the substrate as well as the therapeutic approaches in the ventricular tachyarrhythmias of structural heart diseases will be discussed
Intended Audience
Practicing cardiologists
Cardiologists in training
Electrophyologists
Session II: Novel Interventional and Medical Treatment Options in VTE
Course Description II
In this session we are aiming to update our cardiologists and cardiovascular surgeons on recent special situation of VTE during the pandemic. On the other hand the treatment of VTE has enormously evolved both through pharmacomechanical techniques as well as medical treatments with significant improvements in guideline. The lecturers will be addressing all these issues during the session.
Course Learning Objective
VTE has been one of the major causes of mortality all over the world. The prevalence of VTE has increased during the pandemic for many reasons. In this session we will update the issue with its medical solutions as well as novel interventional treatments.
Intended Audience
Interventional cardiologists, cardiac surgeons, cardiologists, vascular surgeons
Heart Rhythm Journal (HRJ)
Course Description
Title: New treatments for heart rhythm disorders
The course will highlight the important new methods of treatment of cardiac arrhythmia published in Heart Rhythm journal over the past year.
Course Learning Objective
After completing the course, the participants will learn how to
1.perform neuromodulation procedures for arrhythmia control
2.use ganglionated plexi ablation to control syncope
3.use the His bundle pacing and the left bundle branch area pacing to improve the outcomes of pacemaker or CRT implantations
Intended Audience
Clinical cardiac electrophysiologists who perform interventional electrophysiological procedures and device implantations.
Heart Rhythm Society (HRS)
Course Description
Great Wall/International Cardiology Congress (GW/ICC) – Heart Rhythm Society (HRS) Joint symposium has had two decades of collaboration between two international organizations. These four joint sessions will highlight key advances in cardiac rhythm management to keep the practitioner current, with an emphasis on clinical practice and guidelines. The format of the sessions will be case-based presentations engaging faculty and audience participation. Most recent guidelines on AF, sudden cardiac death and stroke prevention will be reviewed by using case-based presentations. Indications and contraindications of the various treatment options and the state of art technology will be discussed by leaders in the field. The management and prevention of stroke in patients with atrial fibrillation, will be reviewed with an update from the most recent guidelines. The COVID-19 pandemic has been the focus of entire globe in 2020. We will exchange our knowledge and experience on our practice during the pandemic. These sessions will be discussed with thought leaders in China and USA Heart Rhythm Society.
Course Learning Objective
Upon conclusion of this GW/ICC-HRS Joint Symposium, participants should be able to:
• Discuss on current guideline on AF management, therapeutic options, update on AF catheter ablation
• Discuss state of art evaluation of suspected inherited heart rhythm disorders in patients with out of hospital cardiac arrest
• Describe the current status of stroke prevention options in atrial fibrillation, especially in the elderly
• Exchange our knowledge and experience on COVID-19 pandemic
Intended Audience
The Symposium is intended for cardiologists, general internists, physician assistants, and cardiovascular nurse practitioners and electrophysiologists learning the practice guidelines and management strategies for rhythm disorders.
International Atherosclerosis Society
Course Description
Session Title: Essentials of Residual Risk
6 lectures on different residual risk factors followed by in depth Q&A
Faculty:
Chairs: Peter Libby (USA), Yida Tang (PRC), Jing Liu (PRC)
Speakers (in order of presentation) : Peter Libby USA), Dong
Zhao (PRC), Raul Santos (Brasil), Changtao Jiang (PRC), Samia Mora (USA), Yida
Tang (PRC).
Course Learning Objective
Cardiovascular diseases are the leading cause of death and disability globally
and are on the rise in developing regions of the world.
Residual risk (RR) refers to the wide range of additional cardiovascular risk factors or biomarkers associated with occurrence/recurrence of cardiovascular events that commonly go unaddressed in the management of atherosclerotic cardiovascular disease. The lack of RR treatment stems from a poor awareness of RR factors, a lack of consensus on how to address RR, and an absence of proven scientific treatments, and a lack of educational programs to address the need.
Intended Audience
Cardiologists, Lipidologists, Internists, endocrinologists and cardiometabolic experts.
Korean Society of Cardio Metabolic Syndrome
Course Description: The current course discusses about Lipoprotein(a) [Lp(a)], a particle that inherits all the atherogenic properties of low-density lipoprotein and thrombogenic traits of the apolipoprotein(a). The course further delineates epidemiologic/clinical studies and therapeutic interventions.
Course Learning Objective: To understand the basic molecular traits of Lp(a) and how novel therapeutic interventions are developed to tackles such characteristics.
Intended Audience: The speakers from Korea and China are renowned physicians and scientists who will give you new insights regarding Lp(a).
Mexican Society of Cardiology
Course Description: During this session, the Faculties will discuss:
1.- Similarities and differences of Cardiovascular Disease presentation and treatment in Diabetic Patients from 2 distant regions of the world.
2.- Review new pharmacological options for diabetic patients, adopted by Cardiologists.
3.- How Acute Coronary Syndromes and Revascularization options in diabetic patients are of particular concern for Cardiologist and Vascular specialists.
Course Learning Objective:
1.- To describe similarities and differences of Cardiovascular Disease presentation in Diabetic Patients from 2 distant regions of the world.
2.- To discuss the clinical characteristics of CVD in diabetic patients and new pharmacological options.
3.- To review the differences of therapeutic approach for CVD in diabetic patients during Acute Coronary Syndromes and Revascularization.
Intended Audience: General practitioners, first contact physicians, Internal Medicine specialists, Endocrinologists, Diabetes Educators, Nutritionists, Cardiologists and vascular specialists.
Nature Review Cardiology
Course Description
Editors and advisory board members of Nature Reviews Cardiology will discuss the process of choosing topics for Review articles and how to write and publish high-impact papers.
Course Learning Objective
How to write and publish high-impact Review articles.
Intended Audience
Cardiologists and postgraduate students
Pacing and Clinical Electrophysiology（PACE）Journal
Session I: Catheter Ablation in Heart Failure Patients with Atrial Fibrillation: Do We Need Another Trial?
Course Description
This course will focus on the current evidence regarding catheter ablation in heart failure patients with atrial fibrillation.
Course Learning Objective
After completion of this course, participants will be able to:
1. Familiarize with the different randomized studies investigating the benefit of ablation in HF patients with AF
2. Recognize AF burden as a new clinically relevant endpoint
3. Understand the need for better patient selection for AF ablation in the HF population
Intended Audience
This activity is designed for all professionals who participate in the care and management of heart rhythm disorders and/or heart failure.
Session II: Cardioembolic Stroke Prevention: Thinking Beyond Arrhythmias
Course Description II This course will focus on the current evidence regarding atrial myopathy as a clinically relevant entity, manifesting with incident atrial arrhythmias and ischemic stroke events.
Course Learning Objective
After completion of this course, participants will be able to:
1.Familiarize with the concept of atrial myopathy as the driver of cardiac arrhythmogenic and thrombogenic substrate.
2.Recognize the role of advanced cardiac imaging in evaluating atrial myopathy markers.
3.Recognize alternative therapeutic perspectives regarding stroke and arrhythmia prevention guided by atrial myopathy markers.
Intended Audience
This activity is designed for all professionals who participate in the care and management of heart rhythm disorders and/or stroke.
Pakistan Cardiac Society (PCS)
Session 1: Heart Failure
Course Description:
We aim to discuss and educate the current trends and updates in the diagnosis, management and prognosis of Heart Failure.
Course Learning Objective
- Heart failure (HF) prevalence and outcomes
- Current HF guidelines
- Role of cardiac imaging in HF management
- Recent advances in medical treatment of HF
- HF management beyond medical treatment
Intended Audience
- Cardiologist, post graduate cardiology trainee and physicians.
- Cardiac nurses
- Cardiac imaging and cathlab technologists
Session 2: Coronary Intervention
Course Description
Comprehensive Review of Complex Coronary Intervention
Course Learning Objective
To learn the stepwise approach in Bifurcation Stenting.
To learn how to perform Left Main Stenting.
To learn various modalities used in the treatment of calcific Coronary Lesions.
To learn the various techniques used in the treatment of chronic coronary total occlusions.
Intended Audience
Trainees and Consultants in Cardiology and Interventional Cardiology.
Philippine Heart Association
Course Description I
Acute dilated cardiomyopathy a novel treatment in children and the management of arrhythmias in DCM given certain limitations in the Philippines
Course Learning Objective
This session will present a novel management of dilated cardiomyopathy as described by Prof. DeitmarSchranz of the University of Giessen, Germany and the available management options of cardiac arrhythmias in dilated cardiomyopathy in developing country like the Philippines
Intended Audience
Critical care, TCVS, and pediatric and adult cardiologists who care for patients with dilated cardiomyopathy
Course Description II
Channellopathies in the Philippines
Course Learning Objective
This session will present channellopathies and discuss how they are managed, given certain limitations, in the Philippines
Intended Audience:
Clinical Cardiologists and Electrophysiologists
The Korean Society of Cardiology
Course Description
- This course is dealing with recent topic in arrhythmia.
Course Learning Objective
- To learn integrated management of AF
- To learn anticoagulation of AF
- To learn sudden cardiac death and inherited arrhythmias
Intended Audience
- Cardiologist, general physician
The Society for Cardiovascular Angiography and Intervention (SCAI)
Course Description
Session 1. Current Data on Structural Heart Disease Management
Moderators: David Zhao, MD, FSCAI + GW-ICC moderator (Jun-Jie Zhang, Nanjing First Hospital, NMU)
Discussants: All speakers + possibly 2 more SCAI and 4 GWICC discussants
Session description. This session will highlight the state-of-the-art of transcatheter approaches for aortic valve disease (primarily aortic stenosis) and mitral valve disease (primarily mitral insufficiency) both globally and in China.
Session 2. Left main and coronary bifurcation interventions
Moderators: SCAI member (G Dangas)+ GW-ICC moderator (Shao-Liang Chen)
Discussants: All speakers + possibly 2 more SCAI and 4 GWICC discussants
Session description. This session will highlight recent advances in coronary intervention both globally and in China. Lectures will focus on new approaches and recent data regarding treatment of left main disease and coronary bifurcation.
Session 3. What we have learnt from latest interventional trials
Moderators: SCAI member + GW-ICC (Yaling Han)
Discussants: All speakers + possibly 2 SCAI and 4 more GW-ICC discussants
Session description. This session will highlight recent advances in interventional cardiology.
Transcatheter Cardiovascular Therapeutics (TCT)
Course Description
Session 1. Advances in Structural Heart Disease Management
Moderators: Gregg W. Stone (gstone@crf.org) + GW-ICC moderator
Discussants: All speakers + possibly 2 more GW-ICC discussants
Session description. This session will highlight the state-of-the-art of transcatheter approaches for aortic valve disease (primarily aortic stenosis) and mitral valve disease (primarily mitral insufficiency) both globally and in China.
Session 2. Advances in PCI 2020
Moderators: Ajay Kirtane (akirtane@crf.org) + GW-ICC moderator (consider HAN Yaling)
Discussants: All speakers + possibly 2 more GW-ICC discussants
Session description. This session will highlight recent advances in coronary intervention both globally and in China. Lectures will focus on new approaches and recent data regarding treatment of left main disease, treatment of calcified lesions, and approaches to STEMI in the era of Covid-19 as well as optimal antiplatelet therapy in high risk patient subsets.
Session 3. New Paradigms in Intravascular Imaging and Physiology
Moderators: Gary Mintz (Gsm18439@aol.com)+ GW-ICC moderator
Discussants: All speakers + possibly 2 more GW-ICC discussants
Session description. This session will highlight recent advances in physiologic lesion assessment both pre- and post PCI, intravascular imaging to guide and optimize PCI procedures, and new intravascular imaging data regarding vulnerable plaque detection and vulnerable plaque and patient assessment and treatment.
Turkish Atherosclerosis Society
Course Description I
To evaluate the up to date status of cardiovascular prevention
Course Learning Objective
Recent developments for atherosclerosis treatment and the prevention of atherosclerotic events in terms of drugs, other prevention measures and public health strategies
Intended Audience
Family physicians, internists, cardiologists, public health specialists
Course Description II
To evaluate relations between infections and atherosclerosis
Course Learning Objective
COVİD-19 pandemic showed bidirectional relation between COVID-19 and atherosclerotic events. This is also true for many acute and chronic infections. The learning objective of this session is to evaluate the infection- atherosclerotic process relation and the clues of prevention.
Intended Audience
Family physicians, internists, cardiologists, infectious disease specialists, emergency physicians, intensive care specialists
World Heart Federation (WHF)
Course Description I
Early evidence on the impact of COVID-19 and CVD
There is emerging evidence that cardiovascular disease, diabetes mellitus, and hypertension are associated with COVID-19 and its severity. Both acute and preexisting CVD impact outcomes unfavourably. The WHF COVID-19 and CVD study aims to better understand the intersection between COVID-19 and CVD.
This session will focus on the global research emerging in the areas of COVID-19 and cardiovascular disease.
Course Learning Objective
To inform participants of the emerging evidence and the way forward in a new global health world amidst the COVID-19 pandemic.
Intended Audience
All leaders working in cardiovascular health with a specific interest in cardiovascular disease and diabetes.
Course Description II
Air pollution and the heart
Air pollution and its impact on people’s health has become a significant issue on the global health agenda. Nine out of ten people worldwide breathe polluted air, which disproportionately affects those living in low-resource settings. Twenty percent of all cardiovascular disease deaths can be attributed to by air pollution—that’s more than three million deaths every year—making air pollution reduction a must for the global health community. This session will focus on air pollution as a CVD risk factor.
Course Learning Objective
To inform participants of the emerging evidence of air pollution and its impact on cardiovascular health.
Intended Audience
All leaders working in cardiovascular health with a specific interest in cardiovascular disease and air pollution.
